Home

Review

Read time: 3 min

Congress highlights

Biomarkers - the Future of Diagnosis in Psychiatry?

Diagnosis of psychiatric disorders currently depends on clinical criteria. In the future the hope...

Read time: 4 min

Use of fidelity scales to ensure and assess high-quality first episode psychosis services

Fidelity scales ensure that services based on evidence deliver high-quality programs and outcomes,...

Depression, Schizophrenia

Making primary care count in mental health provision

Read the full feature here.

Making primary care count in mental health provision

Depression, Schizophrenia

Towards new treatment options for MDD and schizophrenia: a role for D2 receptor partial agonists

Read the full feature here. Download the audio file.

Towards new treatment options for MDD and schizophrenia: a role for D2 receptor partial agonists

Depression, Alzheimer's Disease

Read time: 3 min

Global planning and local action: complementary strategies to tackle dementia

From the corridors of the WHO in Geneva to the shopping malls of Singapore, efforts are being made...

Depression, Schizophrenia

Read time: 3 min

Psychiatric and somatic comorbidities: Can genetics help us understand the link?

Do physical and mental disorders occur together, because they are the result of shared gene...

Depression, Schizophrenia

Read time: 4 min

From doubts about diagnosis to growing certainty on early intervention

‘Nowhere is the search for personalized care more important than in early psychosis. And no...

Depression, Schizophrenia

Read time: 3 min

ICD-11: new and fit for clinical utility and consistency

The new ICD chapter on mental health and behavioral disorders is designed to offer guidelines to...

Depression, Schizophrenia

Read time: 3 min

Making primary care count in mental health provision

In countries with few resources, some recovering from conflict, mental healthcare does not...

Depression, Schizophrenia

Read time: 3 min

Inspiring efforts to improve mental health across countries and ages

Mental ill-health in megacities was the theme for a presidential plenary session at 18th World...

Depression, Schizophrenia

Read time: 4 min

Congress highlights

Towards new treatment options for MDD and schizophrenia: a role for D2 receptor partial agonists

Major depressive disorder (MDD) and schizophrenia share in common the side effect burden associated...

Read time: 5 min

Congress highlights

Updating DSM-5 to improve diagnostic validity and reliability and clinical utility

Clinicians and researchers are invited to submit proposals for revisions to the fifth edition of...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country